Evidence map›Paper›PMID 24616306›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2015

Are we systematically under-dosing patients with fluorouracil?

Kalpesh Patel, Christine A Iacobuzio-Donahue, Paul E Gormley, Scott E Kern, Steven C Cunningham

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kalpesh PatelJohns Hopkins Medical Institutions, Baltimore, MD.
Christine A Iacobuzio-DonahueJohns Hopkins Medical Institutions, Baltimore, MD.
Paul E GormleySt Agnes Cancer Institute, Baltimore, MD.
Scott E KernJohns Hopkins Medical Institutions, Baltimore, MD sk@jhmi.edu.
Steven C CunninghamSt Agnes Cancer Institute, Baltimore, MD.

Funding

Tumor Antigens for Individual Signatures and TherapyP50CA062924 · NCI · JOHNS HOPKINS UNIVERSITY · PI JAFFEE, ELIZABETH M. · 1993 to 2022
$54.6M
NCI NIH HHS CA62924NCI NIH HHS P50 CA062924
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdenocarcinomaAgedAntimetabolites, AntineoplasticCapecitabineChemotherapy, AdjuvantDeoxycytidineDrug Administration ScheduleDuodenal NeoplasmsFemaleFluorouracilHumansMaleMiddle AgedNeoadjuvant TherapyPancreatic NeoplasmsPancreaticoduodenectomyAntimetabolites, AntineoplasticCapecitabineDeoxycytidineFluorouracil

Identifiers

PMID24616306
PMCPMC4334781

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.